Turnaround

The human resources and benefits provider Alight finds itself navigating a complex dual challenge. The company is facing intensified legal...

Urban-Gro is undergoing a significant strategic shift. The company's efforts to divest non-core assets and consolidate its share structure are...

The dissolution of biotechnology firm Vyant Bio continues to proceed at a slower pace than initially outlined. While shareholders approved...

After sitting dormant for more than three decades, the Sangdong tungsten mine in South Korea is once again operational. Canadian-based...

The German software firm TeamViewer faces a challenging period on the stock market, driven by a disappointing annual forecast and...

The year 2026 is viewed by Puma as a challenging transitional period, characterized by inventory reduction and significant restructuring efforts....

French vaccine specialist Valneva has unveiled its full-year 2025 results, presenting a nuanced financial picture that underscores a significant improvement...

The biotech firm Ocugen has staged a remarkable recovery in recent months, capturing renewed attention from institutional investors. This resurgence...

Investors have returned to Battalion Oil with conviction, propelling the company's stock to a gain of approximately 16% on Wednesday....

Biopharmaceutical firm CytomX Therapeutics has positioned itself for a significant clinical push following a substantial equity raise. The company confirmed...